New EEG findings highlighted by DoubleBlind suggest baseline brain rhythms can forecast how intense an ayahuasca experience may feel—useful context for DMV readers.

UCSF neuroscientist Robin Carhart-Harris uses brain imaging and clinical trials to explore how psychedelics alter cognition and mood — and what that could mean for patients in the DMV.

A plain-language guide to 5‑MeO‑DMT—the “God Molecule”—covering effects, risks, early research, legality, and what DC, Maryland, and Virginia residents should know now.

Johns Hopkins researchers put 25 mg oral THC to the test against psilocybin, offering fresh insights for DMV cannabis consumers.